Sprout

CallFixie is an online service that connects customers with tradespeople, known as "Fixies," across Australia. The platform offers a free service that allows customers to post jobs without any sign-up or subscription fees. Fixies can also submit unlimited quotes at no cost. CallFixie aims to simplify the process of finding qualified tradespeople, catering to a wide range of home repair and maintenance needs. By leveraging technology, the platform provides access to a network of verified service providers, ensuring that users can easily find assistance for jobs of any size. With its user-friendly website and mobile applications, CallFixie streamlines the experience of securing essential services throughout Australia.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, focused on the development and commercialization of innovative medicines for iron deficiency, nephrology, and cardio-renal conditions. Incorporated in 2007, Relypsa specializes in non-absorbed polymeric drugs, aiming to address medical needs in these therapeutic areas. Its flagship product, VELTASSA, is a potassium binder used in the treatment of hyperkalemia, a condition characterized by elevated potassium levels in the blood. The company targets overlooked and undertreated conditions that can be managed through gastrointestinal applications. As of late 2016, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, focused on the development and commercialization of innovative medicines for iron deficiency, nephrology, and cardio-renal conditions. Incorporated in 2007, Relypsa specializes in non-absorbed polymeric drugs, aiming to address medical needs in these therapeutic areas. Its flagship product, VELTASSA, is a potassium binder used in the treatment of hyperkalemia, a condition characterized by elevated potassium levels in the blood. The company targets overlooked and undertreated conditions that can be managed through gastrointestinal applications. As of late 2016, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, focused on the development and commercialization of innovative medicines for iron deficiency, nephrology, and cardio-renal conditions. Incorporated in 2007, Relypsa specializes in non-absorbed polymeric drugs, aiming to address medical needs in these therapeutic areas. Its flagship product, VELTASSA, is a potassium binder used in the treatment of hyperkalemia, a condition characterized by elevated potassium levels in the blood. The company targets overlooked and undertreated conditions that can be managed through gastrointestinal applications. As of late 2016, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, focused on the development and commercialization of innovative medicines for iron deficiency, nephrology, and cardio-renal conditions. Incorporated in 2007, Relypsa specializes in non-absorbed polymeric drugs, aiming to address medical needs in these therapeutic areas. Its flagship product, VELTASSA, is a potassium binder used in the treatment of hyperkalemia, a condition characterized by elevated potassium levels in the blood. The company targets overlooked and undertreated conditions that can be managed through gastrointestinal applications. As of late 2016, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

TradeBeam is a provider of Global Trade Management software and services that focuses on streamlining global trading processes for enterprises and their partners. The company offers an integrated solution that enhances import and export compliance and visibility, encompassing inventory management, shipment tracking, and supply chain event management. Additionally, TradeBeam provides global trade finance solutions, including management for open accounts and letters of credit, facilitating smoother international trade operations.

Calix Inc., established in 1999 and headquartered in San Jose, California, specializes in providing cloud-based platforms and software systems to communication service providers (CSPs) worldwide. Its offerings include Calix Cloud, an analytics platform for CSP professionals; Calix Marketing Cloud and Support Cloud for marketing and customer support teams respectively; Experience eXtensible Operating System for residential, business, and mobile subscribers; and Access eXtensible Operating System tailored for access networks. These platforms enable CSPs to simplify their operations, deliver advanced broadband services, and enhance subscriber experiences, ultimately driving growth in subscriber acquisition, loyalty, and revenue. Calix serves customers across the United States, Middle East, Europe, Asia Pacific, and other regions, primarily through its direct sales force and resellers.

CareDx, Inc. is a precision medicine company that specializes in developing and commercializing innovative healthcare solutions for transplant patients and their caregivers. The company offers a range of molecular diagnostics products, including AlloSure Kidney and AlloMap Heart, which utilize donor-derived cell-free DNA to assess organ transplant health and identify potential rejections noninvasively. CareDx also provides various solutions for human leukocyte antigen typing, chimerism testing, and post-transplant monitoring. Its offerings extend to patient tracking software and predictive analysis tools, enhancing the overall transplant experience from initial matching to ongoing care. Founded in 1998 and headquartered in South San Francisco, California, CareDx has established partnerships for the development and distribution of advanced genomic testing technologies, further solidifying its role as a leader in transplant diagnostics.

AffyMax, Inc. is a biopharmaceutical company based in New York, founded in 2001, that focuses on developing innovative peptide-based therapeutics for the treatment of serious conditions. The company's primary product, OMONTYS, is a synthetic erythropoiesis-stimulating agent designed to treat anemia associated with chronic kidney disease in adult patients on dialysis. OMONTYS is notable for being the only once-monthly erythropoiesis-stimulating agent available for this patient population in the United States. Although the company has faced challenges and currently does not have significant operations, it previously pursued the development of peginesatide, which was under review by the U.S. Food and Drug Administration for the same indication.

Labcyte Inc., founded in 2000 and based in San Jose, California, specializes in developing acoustic droplet ejection (ADE) technology for various applications in the life sciences. The company's innovative approach uses focused beams of acoustic energy to precisely dispense nanoliter-scale droplets of fluid from one plate to another, enabling high accuracy at low volumes and reducing consumables costs. Labcyte's products include automation systems, laboratory workstations, and control software, which are utilized in drug discovery, genomics research, cancer research, and personalized medicine. The company operates as a subsidiary of Beckman Coulter, Inc., with additional offices across multiple countries including Canada, the United Kingdom, Australia, India, South Korea, China, Hong Kong, Japan, Singapore, and Taiwan.

Relypsa, Inc. is a biopharmaceutical company based in Redwood City, California, focused on the development and commercialization of innovative medicines for iron deficiency, nephrology, and cardio-renal conditions. Incorporated in 2007, Relypsa specializes in non-absorbed polymeric drugs, aiming to address medical needs in these therapeutic areas. Its flagship product, VELTASSA, is a potassium binder used in the treatment of hyperkalemia, a condition characterized by elevated potassium levels in the blood. The company targets overlooked and undertreated conditions that can be managed through gastrointestinal applications. As of late 2016, Relypsa operates as a subsidiary of Vifor Pharma Ltd.

Barricaid is a medical device company that specializes in developing therapeutic solutions for patients undergoing back surgery. Their primary product is a bone-anchored implant designed to reduce the incidence of reherniation and reoperation in patients with large annular defects. The implant works by physically blocking the annulus at the post-surgery defect, using a titanium alloy anchor component that secures the device in position within either the caudal or cranial-adjacent vertebral body. This innovative approach aims to improve outcomes for patients who are at high risk of requiring repeated surgeries due to herniation following lumbar discectomy surgery, particularly those suffering from sciatica.

TradeBeam is a provider of Global Trade Management software and services that focuses on streamlining global trading processes for enterprises and their partners. The company offers an integrated solution that enhances import and export compliance and visibility, encompassing inventory management, shipment tracking, and supply chain event management. Additionally, TradeBeam provides global trade finance solutions, including management for open accounts and letters of credit, facilitating smoother international trade operations.

NeuroVista Corporation is a medical device company based in Seattle, Washington, focused on developing innovative technologies for the management and treatment of epilepsy in the United States. Founded in 2002 and originally known as BioNeuronics Corporation until its rebranding in 2007, NeuroVista aims to address the challenges faced by the approximately 3 million Americans living with epilepsy, a neurological condition characterized by unpredictable seizures. These seizures can vary significantly in severity and impact daily life, affecting individuals primarily between the ages of 15 and 64. Through its advisory technologies, NeuroVista seeks to provide tools that help mitigate the uncertainty surrounding the timing of epileptic seizures, ultimately improving the quality of life for those affected by this condition.

Spine Wave, Inc. is a medical device company that specializes in the development and marketing of innovative solutions for spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company offers a diverse range of products including expandable PEEK spacers, interbody devices for posterior surgery, and lateral stabilization systems. Its offerings also encompass the GraftMag Graft Delivery System for large bone graft delivery, fixation products for treating thoracolumbar spine conditions, and anterior cervical plate systems for spinal fusion. Spine Wave prioritizes a surgeon-driven product development approach, enabling it to create a differentiated portfolio of less invasive and efficient surgical solutions aimed at restoring spinal function and improving patients' quality of life. The company's products are distributed through various channels, ensuring wide accessibility for spine surgeons and their patients.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Kalypsys specializes in pathway-based drug discovery and development services. The company conducts discovery programs across a wide range of therapeutic areas, leveraging its automated and integrated suite of technologies in biology, chemistry, and informatics. By utilizing advanced methodologies, Kalypsys aims to enhance the efficiency and effectiveness of the drug discovery process, ultimately contributing to the development of innovative therapies.

Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.

Reliance Globalcom, a division of Reliance Communications, leads the global telecommunications operations of India's largest integrated telecom service provider. The company integrates various services, including enterprise solutions, capacity sales, managed services, and a wide range of retail offerings such as global voice, internet solutions, and value-added services. Reliance Globalcom caters to a diverse clientele, serving over 2,100 enterprises, 200 carriers, and approximately 2.2 million retail customers across 163 countries and six continents.

Spine Wave, Inc. is a medical device company that specializes in the development and marketing of innovative solutions for spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company offers a diverse range of products including expandable PEEK spacers, interbody devices for posterior surgery, and lateral stabilization systems. Its offerings also encompass the GraftMag Graft Delivery System for large bone graft delivery, fixation products for treating thoracolumbar spine conditions, and anterior cervical plate systems for spinal fusion. Spine Wave prioritizes a surgeon-driven product development approach, enabling it to create a differentiated portfolio of less invasive and efficient surgical solutions aimed at restoring spinal function and improving patients' quality of life. The company's products are distributed through various channels, ensuring wide accessibility for spine surgeons and their patients.

CareDx, Inc. is a precision medicine company that specializes in developing and commercializing innovative healthcare solutions for transplant patients and their caregivers. The company offers a range of molecular diagnostics products, including AlloSure Kidney and AlloMap Heart, which utilize donor-derived cell-free DNA to assess organ transplant health and identify potential rejections noninvasively. CareDx also provides various solutions for human leukocyte antigen typing, chimerism testing, and post-transplant monitoring. Its offerings extend to patient tracking software and predictive analysis tools, enhancing the overall transplant experience from initial matching to ongoing care. Founded in 1998 and headquartered in South San Francisco, California, CareDx has established partnerships for the development and distribution of advanced genomic testing technologies, further solidifying its role as a leader in transplant diagnostics.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Radiant Medical is a private medical device company based in Redwood City, California, founded in 1999. The company specializes in endovascular temperature therapy, focusing on innovative solutions for the treatment of heart, brain, and kidney disorders. Radiant Medical's primary product is a comprehensive system that includes a single-use central venous heat exchange balloon catheter, a heat exchange cassette, a microprocessor-driven controller, and an integrated temperature sensor. This system enables healthcare providers to safely and efficiently control patient core body temperature, allowing for rapid cooling, maintenance, and warming as needed during medical procedures.

LeftHand Networks Inc. specializes in data storage systems and IP-based storage area networks (SAN). The company provides iSCSI SANs that consist of multiple storage nodes integrated into a single system, along with virtual storage systems and evaluation software such as SAN/iQ software. These offerings allow for the aggregation of disparate resources into a unified storage solution. Additionally, LeftHand Networks delivers IT project solutions encompassing disaster recovery and data center virtualization, as well as application solutions for various platforms, including data protection and server applications. The company serves diverse industries such as education, government, financial services, and healthcare, distributing its products through resellers and distributors across the United States, Canada, and Europe. Founded in 1999 and headquartered in Boulder, Colorado, LeftHand Networks also maintains offices in the United Kingdom and the Netherlands. As of 2008, it operates as a subsidiary of Hewlett-Packard Company.

Direct Flow Medical is a medical device company specializing in the development of innovative transcatheter aortic valve replacement systems aimed at treating heart valve diseases. The company's primary focus is on creating a percutaneous aortic tissue valve prosthesis, which offers patients suffering from cardiac valve insufficiency a safe and effective treatment option. With approximately 1.2 million individuals over the age of 65 affected by calcified aortic valves, and only about 150,000 receiving surgical intervention annually, Direct Flow Medical addresses a significant gap in patient care. Their technology allows heart surgeons to conduct repeated assessments of hemodynamic performance prior to final implantation, thereby enhancing patient outcomes and minimizing complications associated with invasive surgeries.

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

AffyMax, Inc. is a biopharmaceutical company based in New York, founded in 2001, that focuses on developing innovative peptide-based therapeutics for the treatment of serious conditions. The company's primary product, OMONTYS, is a synthetic erythropoiesis-stimulating agent designed to treat anemia associated with chronic kidney disease in adult patients on dialysis. OMONTYS is notable for being the only once-monthly erythropoiesis-stimulating agent available for this patient population in the United States. Although the company has faced challenges and currently does not have significant operations, it previously pursued the development of peginesatide, which was under review by the U.S. Food and Drug Administration for the same indication.

Yipes is a data communications services provider. It was acquired in 2007 by Indian telecommunications service provider Reliance Communications. Yipes delivers scalable business-to-business and business-to-Internet IP networking services. Their regional IP network Yipes MAN seamlessly extends your company's LAN to other business locations or to business partner locations. Their Yipes NET Internet service brings the Web to your LAN at breakaway speeds. Yipes NET customers can also take advantage of Yipes' industry-leading security offering Yipes WALL managed firewall service, to safeguard their private information from the dangers of the public Internet. Yipes NAN replaces private line and frame relay services with the simplicity of Ethernet. Yipes WEB offers a full portfolio of Internet management services. Yipes TOUGH enables customers to extend the redundancy on their customer premise to the Yipes Network.

Reliance Globalcom, a division of Reliance Communications, leads the global telecommunications operations of India's largest integrated telecom service provider. The company integrates various services, including enterprise solutions, capacity sales, managed services, and a wide range of retail offerings such as global voice, internet solutions, and value-added services. Reliance Globalcom caters to a diverse clientele, serving over 2,100 enterprises, 200 carriers, and approximately 2.2 million retail customers across 163 countries and six continents.

Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.

NeuroBionics Corp. researches and develops medical devices for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, obesity, and depression.

CareDx, Inc. is a precision medicine company that specializes in developing and commercializing innovative healthcare solutions for transplant patients and their caregivers. The company offers a range of molecular diagnostics products, including AlloSure Kidney and AlloMap Heart, which utilize donor-derived cell-free DNA to assess organ transplant health and identify potential rejections noninvasively. CareDx also provides various solutions for human leukocyte antigen typing, chimerism testing, and post-transplant monitoring. Its offerings extend to patient tracking software and predictive analysis tools, enhancing the overall transplant experience from initial matching to ongoing care. Founded in 1998 and headquartered in South San Francisco, California, CareDx has established partnerships for the development and distribution of advanced genomic testing technologies, further solidifying its role as a leader in transplant diagnostics.

TradeBeam is a provider of Global Trade Management software and services that focuses on streamlining global trading processes for enterprises and their partners. The company offers an integrated solution that enhances import and export compliance and visibility, encompassing inventory management, shipment tracking, and supply chain event management. Additionally, TradeBeam provides global trade finance solutions, including management for open accounts and letters of credit, facilitating smoother international trade operations.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.

Kalypsys specializes in pathway-based drug discovery and development services. The company conducts discovery programs across a wide range of therapeutic areas, leveraging its automated and integrated suite of technologies in biology, chemistry, and informatics. By utilizing advanced methodologies, Kalypsys aims to enhance the efficiency and effectiveness of the drug discovery process, ultimately contributing to the development of innovative therapies.

Evolution Benefits is a company that focuses on enhancing healthcare management through innovative software and payment solutions. It specializes in administering and managing consumer-directed accounts, including defined contribution plans, health savings accounts, health reimbursement arrangements, flexible spending accounts, and various wellness and transit plans. The company aims to help clients improve financial health and employee satisfaction by developing customized employee benefit strategies that align with their organizational objectives. By taking a comprehensive approach, Evolution Benefits designs and implements tailored programs that address the unique demographics and culture of each client, ensuring a cost-effective benefits package that meets their specific needs.

AffyMax, Inc. is a biopharmaceutical company based in New York, founded in 2001, that focuses on developing innovative peptide-based therapeutics for the treatment of serious conditions. The company's primary product, OMONTYS, is a synthetic erythropoiesis-stimulating agent designed to treat anemia associated with chronic kidney disease in adult patients on dialysis. OMONTYS is notable for being the only once-monthly erythropoiesis-stimulating agent available for this patient population in the United States. Although the company has faced challenges and currently does not have significant operations, it previously pursued the development of peginesatide, which was under review by the U.S. Food and Drug Administration for the same indication.

Aspreva Pharmaceuticals Corp is a pharmaceutical company based in Victoria, British Columbia, dedicated to developing and commercializing new indications for existing drugs aimed at underserved patient populations. The company specializes in identifying late-stage and approved medications that have the potential for significant therapeutic benefits in less common diseases. Through a strategy known as "indication partnering," Aspreva collaborates with other pharmaceutical and biopharmaceutical companies to gain rights for the development of these drugs in new therapeutic areas. This approach encompasses clinical research, regulatory approvals, and the commercialization of products tailored for complex diseases and specialized patient groups. By focusing on innovative therapeutic solutions, Aspreva aims to address unmet medical needs and improve patient outcomes.

Spiration, Inc., also known as Olympus Respiratory America, is a medical device company based in Redmond, Washington. Founded in 1999, the company specializes in the development of innovative solutions for the treatment of lung diseases and air leaks. Its flagship product, the IBV valve system, is a minimally invasive device designed to redirect airflow from affected areas of the lung to healthier regions, addressing both acute and chronic conditions such as emphysema and prolonged air leaks. Operating as a subsidiary of Olympus America Inc. since 2010, Spiration focuses on enhancing respiratory health through advanced medical technology.

NeuroVista Corporation is a medical device company based in Seattle, Washington, focused on developing innovative technologies for the management and treatment of epilepsy in the United States. Founded in 2002 and originally known as BioNeuronics Corporation until its rebranding in 2007, NeuroVista aims to address the challenges faced by the approximately 3 million Americans living with epilepsy, a neurological condition characterized by unpredictable seizures. These seizures can vary significantly in severity and impact daily life, affecting individuals primarily between the ages of 15 and 64. Through its advisory technologies, NeuroVista seeks to provide tools that help mitigate the uncertainty surrounding the timing of epileptic seizures, ultimately improving the quality of life for those affected by this condition.

Visiogen, Inc. is an ophthalmic medical device company focused on creating innovative vision solutions for cataract patients, including those with presbyopia. The company's flagship product is the Synchrony dual optic accommodating intraocular lens (IOL), designed to deliver a seamless vision experience across near, intermediate, and distance ranges without the need for corrective eyewear. To enhance surgical efficiency, the Synchrony IOL is supplied in a pre-loaded injector, minimizing lens handling during procedures. This advanced technology has received CE Mark approval in Europe and is currently undergoing clinical trials in the United States, reflecting Visiogen's commitment to improving patient outcomes in cataract surgery.

Auxilium Pharmaceuticals, founded in 1999, specializes in the development and marketing of pharmaceutical products primarily aimed at urology and sexual health disorders. The company is committed to improving patient outcomes through the identification, development, and commercialization of innovative specialty biopharmaceuticals. Over the years, Auxilium has expanded its mission to address a broader range of unmet medical needs, focusing on creating novel treatment options that enhance the quality of life for patients dealing with various health challenges.

Storability Software specializes in enterprise storage resource management solutions designed to streamline and centralize the administration of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers organizations to better understand and manage their storage assets. By utilizing Storability Software's offerings, customers experience enhanced asset utilization, improved management efficiency, superior service quality, and increased availability of their storage resources. The company's focus on simplifying storage management allows clients to maximize their investment in storage technology.

Infinera Corporation is a global provider of optical transport networking equipment, software, and services, headquartered in Sunnyvale, California. The company specializes in photonic integration technology, offering a diverse portfolio that includes modular platforms, coherent optical transport systems, and packet-optical transport solutions. Its products, such as the Infinera Groove series and 7300 series, cater to various transport network applications, enabling high-capacity data transmission and management. Infinera's digital transport node system incorporates advanced technology for digital processing of network traffic. The company also provides a range of support services, including technical support, installation, and professional services. Infinera's customer base consists of telecommunications service providers, internet content providers, cable operators, research institutions, large enterprises, and government entities, all of whom rely on its solutions for efficient optical networking. Founded in 2000, Infinera continues to innovate in the field of optical networking, enhancing the capabilities of global communications infrastructure.

Progen Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. The company's products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Redwood City, California. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. As a result of the acquisition of Cellgate, Inc. by Progen Pharmaceuticals Limited, Cellgate's name was changed. As of February 7, 2008, Progen Pharmaceuticals, Inc. operates as a subsidiary of Progen Pharmaceuticals Limited (ASX: PGL).

Ilypsa is a pharmaceutical company based in Santa Clara, California, focused on developing treatments for renal care. Founded in 2002, Ilypsa specializes in creating non-absorbed polymeric compounds that bind to phosphate and potassium in the digestive tract, preventing their absorption into the body. These compounds are designed to treat complications of kidney diseases, such as hyperphosphatemia, which is characterized by high blood levels of phosphorus. The company was previously known as Symyx Therapeutics.

Evolution Benefits is a company that focuses on enhancing healthcare management through innovative software and payment solutions. It specializes in administering and managing consumer-directed accounts, including defined contribution plans, health savings accounts, health reimbursement arrangements, flexible spending accounts, and various wellness and transit plans. The company aims to help clients improve financial health and employee satisfaction by developing customized employee benefit strategies that align with their organizational objectives. By taking a comprehensive approach, Evolution Benefits designs and implements tailored programs that address the unique demographics and culture of each client, ensuring a cost-effective benefits package that meets their specific needs.

Sirna Therapeutics is a biotechnology company focused on developing therapies based on RNA interference (RNAi), a groundbreaking scientific discovery with the potential to transform disease treatment. By harnessing the capabilities of RNAi, Sirna Therapeutics aims to create innovative solutions that address various illnesses, positioning itself at the forefront of this emerging field. The company's commitment to advancing RNAi-based therapies highlights its role in the evolving landscape of medical treatment, with the goal of improving patient outcomes through targeted interventions.

LeftHand Networks Inc. specializes in data storage systems and IP-based storage area networks (SAN). The company provides iSCSI SANs that consist of multiple storage nodes integrated into a single system, along with virtual storage systems and evaluation software such as SAN/iQ software. These offerings allow for the aggregation of disparate resources into a unified storage solution. Additionally, LeftHand Networks delivers IT project solutions encompassing disaster recovery and data center virtualization, as well as application solutions for various platforms, including data protection and server applications. The company serves diverse industries such as education, government, financial services, and healthcare, distributing its products through resellers and distributors across the United States, Canada, and Europe. Founded in 1999 and headquartered in Boulder, Colorado, LeftHand Networks also maintains offices in the United Kingdom and the Netherlands. As of 2008, it operates as a subsidiary of Hewlett-Packard Company.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

WaterCove Networks is a provider of innovative data networking infrastructure tailored for wireless service providers aiming to efficiently deploy next-generation mobile data services. Established in 2000 and privately held, the company offers a Mobile Data Service System designed to facilitate the rapid rollout of high-speed data services in various wireless environments, including 2.5G and 3G networks. This system addresses common challenges faced by operators, such as performance and provisioning obstacles, by utilizing the proprietary FlowCore architecture, which enables a smooth transition to advanced technologies without the need for costly upgrades. WaterCove Networks focuses on empowering carriers to customize their service delivery and charging structures, resulting in personalized mobile data experiences for both enterprise and consumer customers. The company is led by a seasoned management team with extensive experience in telecommunications and is supported by significant investment, positioning it as a key player in the evolving landscape of mobile connectivity.

Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.

Barricaid is a medical device company that specializes in developing therapeutic solutions for patients undergoing back surgery. Their primary product is a bone-anchored implant designed to reduce the incidence of reherniation and reoperation in patients with large annular defects. The implant works by physically blocking the annulus at the post-surgery defect, using a titanium alloy anchor component that secures the device in position within either the caudal or cranial-adjacent vertebral body. This innovative approach aims to improve outcomes for patients who are at high risk of requiring repeated surgeries due to herniation following lumbar discectomy surgery, particularly those suffering from sciatica.

Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.

Supply Solutions is an online based company selling industrial supplies.

Epocrates is a developer of mobile and online clinical information and decision support software aimed at healthcare professionals. The company provides a range of tools, including an integrated diagnostic suite, a comprehensive drug reference guide, and resources for ICD-9 and CPT coding, as well as medical terminology. Additionally, Epocrates offers a free learning center for on-the-go education. With a significant user base, including one-third of U.S. physicians and medical students, Epocrates enables healthcare providers to access critical information quickly and confidently at the point of care, complementing its offerings with market research and formulary hosting services.

Internet Photonics, Inc. is a growth-oriented company specializing in optical Ethernet transport and switching solutions for telecommunications service providers. It is known for its development of the first carrier-grade Intelligent Wavelength Platforms, enabling network operators, including service providers and cable multiple system operators, to offer high-bandwidth data services alongside their legacy offerings. The company's innovative products facilitate efficient data transmission and enhance service profitability, positioning Internet Photonics as a key player in the evolving telecommunications landscape.

Sensys Medical develops a non-invasive blood glucose monitor that used near-infrared diffuse reflectance spectroscopy.

Blue Falcon provides the most cost-effective, high quality, and easily deployed digital content delivery solutions. With centralized network control, decentralized distribution, and integration with industry leading DRM solutions, Blue Falcon provides groundbreaking digital delivery efficiencies within a securely managed network. Blue Falcon's suite of solutions meets a broad range of digital delivery needs including: live audio and video streaming, on-demand music and movies, and large file and application downloads. The company's target customer base includes digital content providers, traditional/web broadcasters, and Global 1000 corporations. Blue Falcon's rapidly growing customer base includes Radio Free Virgin and Salem Communications. Corporate headquarters are in downtown Los Angeles in the historic Bradbury Building.

Visiogen, Inc. is an ophthalmic medical device company focused on creating innovative vision solutions for cataract patients, including those with presbyopia. The company's flagship product is the Synchrony dual optic accommodating intraocular lens (IOL), designed to deliver a seamless vision experience across near, intermediate, and distance ranges without the need for corrective eyewear. To enhance surgical efficiency, the Synchrony IOL is supplied in a pre-loaded injector, minimizing lens handling during procedures. This advanced technology has received CE Mark approval in Europe and is currently undergoing clinical trials in the United States, reflecting Visiogen's commitment to improving patient outcomes in cataract surgery.

Storability Software specializes in enterprise storage resource management solutions designed to streamline and centralize the administration of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers organizations to better understand and manage their storage assets. By utilizing Storability Software's offerings, customers experience enhanced asset utilization, improved management efficiency, superior service quality, and increased availability of their storage resources. The company's focus on simplifying storage management allows clients to maximize their investment in storage technology.

Labcyte Inc., founded in 2000 and based in San Jose, California, specializes in developing acoustic droplet ejection (ADE) technology for various applications in the life sciences. The company's innovative approach uses focused beams of acoustic energy to precisely dispense nanoliter-scale droplets of fluid from one plate to another, enabling high accuracy at low volumes and reducing consumables costs. Labcyte's products include automation systems, laboratory workstations, and control software, which are utilized in drug discovery, genomics research, cancer research, and personalized medicine. The company operates as a subsidiary of Beckman Coulter, Inc., with additional offices across multiple countries including Canada, the United Kingdom, Australia, India, South Korea, China, Hong Kong, Japan, Singapore, and Taiwan.

Captura Software, established in September 1994, specializes in offering large companies comprehensive solutions for managing and reducing costs. The company focuses on Total Expense Management solutions that automate expense management through web-based technology, enabling organizations to capture crucial financial data for informed decision-making. These solutions can be deployed globally, accessible to users via standard web browsers with an Internet connection. Captura's applications are centrally hosted and maintained, providing flexibility in deployment options. To further enhance its offerings, Captura forms strategic alliances across various sectors, including finance, software, travel, and communications. These collaborations assist clients in designing and implementing integrated solutions for effective expense data capture and analysis across their enterprises.

Spiration, Inc., also known as Olympus Respiratory America, is a medical device company based in Redmond, Washington. Founded in 1999, the company specializes in the development of innovative solutions for the treatment of lung diseases and air leaks. Its flagship product, the IBV valve system, is a minimally invasive device designed to redirect airflow from affected areas of the lung to healthier regions, addressing both acute and chronic conditions such as emphysema and prolonged air leaks. Operating as a subsidiary of Olympus America Inc. since 2010, Spiration focuses on enhancing respiratory health through advanced medical technology.

Aurora Networks specializes in the development of optical transport equipment tailored for hybrid fiber coaxial (HFC) networks, which are widely utilized by cable television operators. The company focuses on creating advanced optical transport systems that facilitate the integration of digital broadband, voice, video, and data applications. Aurora's product offerings include headend and hub solutions, power supplies, special application back plates, CWDM Ethernet access systems, optical node products, Wi-Fi equipment, and field passives such as optical splitters and combiners. Additionally, they provide single-channel DWDM optical filters and optical mix modules, all designed to enhance the return on investment for broadband service providers.

Kalypsys specializes in pathway-based drug discovery and development services. The company conducts discovery programs across a wide range of therapeutic areas, leveraging its automated and integrated suite of technologies in biology, chemistry, and informatics. By utilizing advanced methodologies, Kalypsys aims to enhance the efficiency and effectiveness of the drug discovery process, ultimately contributing to the development of innovative therapies.

DynamicSoft offers carrier-class infrastructure software designed for packet-based wireline and wireless communications networks. The company's solutions enable carriers and communications application service providers to implement telephony applications and converged services over Internet Protocol networks. Central to its offerings is the dynamicsoft Service Engine, which facilitates mobile carriers in delivering voice and data services over packet networks. This platform also provides a transition pathway to IP 3G network environments and supports a range of services, including voice, multimedia messaging, instant messaging, and presence. Additionally, it consolidates essential functions such as customer data storage, authentication, authorization, provisioning, and service interaction. Established in 1998, DynamicSoft is headquartered in East Hanover, New Jersey.

Silicon Access Networks is a provider of an ultra-high performance chipsets for terabit routers and communication silicon to the networking and telecommunications market.

Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols such as molecules to create potent medications.

Funded in May 2000, Opthos capitalizes on newly-developed, highly innovative technologies. Their goal is to deliver optical networking products that satisfy the overwhelming need by communications carriers for high agility, very low cost solutions.

Protedyne is a subsidiary of Laboratory Corporation of America, specializing in the development of laboratory automation systems aimed at enhancing efficiency in the pharmaceutical and biotech sectors. The company employs industrial automation design principles to create advanced robotic systems that integrate powerful hardware and a comprehensive software infrastructure for data management and process tracking. Protedyne’s solutions include an enclosed platform featuring a 4-axis robotic arm, which facilitates flexible configurations and optimizes workspace utilization. By implementing these automation technologies, Protedyne enables laboratories to streamline their operations and improve productivity in diagnostic testing and related processes. The company is also ISO 13485:2003 Registered, ensuring adherence to quality management standards in its operations.

Storability Software specializes in enterprise storage resource management solutions designed to streamline and centralize the administration of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers organizations to better understand and manage their storage assets. By utilizing Storability Software's offerings, customers experience enhanced asset utilization, improved management efficiency, superior service quality, and increased availability of their storage resources. The company's focus on simplifying storage management allows clients to maximize their investment in storage technology.

Atesto is an automated Web testing service that enables organizations to develop, deploy and monitor Web applications without needing to license, install and manage software and hardware systems and infrastructure. The company’s software suite, Atesto Functional Test, tests and validates complex, static and dynamic Web applications. The company also offers load testing and monitoring services, to address performance and application maintenance needs. The Automated Load Test services simulate complex real-life application scenarios using live Internet traffic from a globally distributed network and the Response Watch service features periodic transaction and Web application monitoring capability from global locations. Both services include detailed, real-time, online reports on application performance and analysis.

Infinera Corporation is a global provider of optical transport networking equipment, software, and services, headquartered in Sunnyvale, California. The company specializes in photonic integration technology, offering a diverse portfolio that includes modular platforms, coherent optical transport systems, and packet-optical transport solutions. Its products, such as the Infinera Groove series and 7300 series, cater to various transport network applications, enabling high-capacity data transmission and management. Infinera's digital transport node system incorporates advanced technology for digital processing of network traffic. The company also provides a range of support services, including technical support, installation, and professional services. Infinera's customer base consists of telecommunications service providers, internet content providers, cable operators, research institutions, large enterprises, and government entities, all of whom rely on its solutions for efficient optical networking. Founded in 2000, Infinera continues to innovate in the field of optical networking, enhancing the capabilities of global communications infrastructure.

MarketFirst Software, Inc. is a company that specializes in developing software and hosted e-marketing solutions for organizations looking to execute marketing campaigns online. Founded in 1996 and based in Mountain View, California, MarketFirst offers a comprehensive e-marketing software platform, along with software templates known as eMarketing Blueprints to assist in campaign creation. Additionally, the company provides a hosted service and offers strategic consulting and implementation services to enhance clients' e-marketing efforts.

Phylos is dedicated to the discovery and development of novel biopharmaceuticals.

WaterCove Networks is a provider of innovative data networking infrastructure tailored for wireless service providers aiming to efficiently deploy next-generation mobile data services. Established in 2000 and privately held, the company offers a Mobile Data Service System designed to facilitate the rapid rollout of high-speed data services in various wireless environments, including 2.5G and 3G networks. This system addresses common challenges faced by operators, such as performance and provisioning obstacles, by utilizing the proprietary FlowCore architecture, which enables a smooth transition to advanced technologies without the need for costly upgrades. WaterCove Networks focuses on empowering carriers to customize their service delivery and charging structures, resulting in personalized mobile data experiences for both enterprise and consumer customers. The company is led by a seasoned management team with extensive experience in telecommunications and is supported by significant investment, positioning it as a key player in the evolving landscape of mobile connectivity.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Silicon Access Networks is a provider of an ultra-high performance chipsets for terabit routers and communication silicon to the networking and telecommunications market.

Supply Solutions is an online based company selling industrial supplies.

Phase Forward is a prominent provider of integrated data management solutions specifically designed for clinical trials and drug safety. Founded in 1997 by Paul Bleicher, M.D., Ph.D., the company aimed to transition life sciences organizations from traditional paper-based methods to innovative, Internet-enabled solutions. Its flagship product, InForm, has significantly advanced electronic data capture, transforming how clinical data is collected, analyzed, and managed. Phase Forward's technology and global services facilitate the automation and integration of the clinical development process, encompassing study initiation, FDA submission, and post-marketing studies. The company's acquisition of Lincoln Technologies enhanced its capabilities, allowing it to offer comprehensive solutions for tracking and monitoring product efficacy and safety, ultimately leading to more efficient and cost-effective trial management. Prior to its acquisition by Oracle in 2010, Phase Forward was headquartered in Waltham, Massachusetts, with additional offices in the UK, Japan, France, and Australia.

Epocrates is a developer of mobile and online clinical information and decision support software aimed at healthcare professionals. The company provides a range of tools, including an integrated diagnostic suite, a comprehensive drug reference guide, and resources for ICD-9 and CPT coding, as well as medical terminology. Additionally, Epocrates offers a free learning center for on-the-go education. With a significant user base, including one-third of U.S. physicians and medical students, Epocrates enables healthcare providers to access critical information quickly and confidently at the point of care, complementing its offerings with market research and formulary hosting services.

Vasca is a medical device company that provides technologies to improve body access for therapeutic interventions in the United States and European Union. The company develops, manufactures, and markets LifeSite, a subcutaneous device that combines a valve with cannulas, which are used for the treatment of chronic renal failure. Vasca was founded in 1996 and is based in Tewksbury, Massachusetts, United States.

Astral Point Communications develops transmission network elements aimed at metropolitan optical access to the internet.

DynamicSoft offers carrier-class infrastructure software designed for packet-based wireline and wireless communications networks. The company's solutions enable carriers and communications application service providers to implement telephony applications and converged services over Internet Protocol networks. Central to its offerings is the dynamicsoft Service Engine, which facilitates mobile carriers in delivering voice and data services over packet networks. This platform also provides a transition pathway to IP 3G network environments and supports a range of services, including voice, multimedia messaging, instant messaging, and presence. Additionally, it consolidates essential functions such as customer data storage, authentication, authorization, provisioning, and service interaction. Established in 1998, DynamicSoft is headquartered in East Hanover, New Jersey.

eFinance's innovative solutions enable companies to quickly and accurately gauge the financial soundness of their customers at each step of the financial supply chain. Their solutions strengthen the credit evaluation process and enable customers to better manage transaction workflow. Customers leverage eFinance technology to increase revenue and profitability while expanding their end customer base and improving customer retention and satisfaction.

MuseumShop.com has established partnerships and affiliations with more than 44 museums worldwide and showcases more than 3,500 products ranging from home decor to fine prints.

Funded in May 2000, Opthos capitalizes on newly-developed, highly innovative technologies. Their goal is to deliver optical networking products that satisfy the overwhelming need by communications carriers for high agility, very low cost solutions.

LiquidPrice.com is a consumer-driven online marketplace where retailers offer brand name products and services in a competitive environment.

CarrierPoint is a logistics software company founded in 1999 by Cliff Isaacson and John Thomson, located in Georgia. It specializes in developing web-based applications that enhance communication and coordination between shippers, carriers, and brokers in real time. The company's solutions facilitate the management of freight movements and include tools for compliance, monitoring, and collaboration. Its compliance offerings encompass services such as electronic requests for quotation, contract management, shipment rating, scheduling, and freight payment. Monitoring features provide status tracking, delivery confirmation, and analysis reporting. Additionally, CarrierPoint supports both planned and unplanned collaboration, along with integration services that streamline operations within a shipper's back office.

Edupoint is a provider of a comprehensive data management solution tailored for K-12 education. Its flagship product, the Synergy® Education Platform, includes a robust student information system (SIS), a learning management system (LMS), and a special education management module. By integrating these components, Edupoint enables school districts to effectively manage student information, learning processes, and special education needs. The platform facilitates informed decision-making by connecting educators with essential data, ultimately aiming to enhance district and student performance and maximize student achievement.

Skila is an internet company providing business intelligence and eKnowledge solutions for the pharmaceutical and biotechnology industries.

Excess Bandwidth Corp. specializes in the development of algorithms and high-performance integrated circuits designed for high-bandwidth communications. The company focuses on creating symmetrical digital subscriber line physical-layer chips and mixed signal semiconductors that facilitate the connection of Internet voice and data services across multiple devices using copper twisted-pair wires. Established in 1998, Excess Bandwidth is recognized for being the first to develop technology that complies with the G.shdsl/HDSL2 high-speed symmetric DSL specifications set by international standards bodies, allowing efficient transmission of high-speed voice and data over a single pair of wires. As a privately held entity, the company is funded through venture capital.

BrightLink Networks, Inc. is a manufacturer of optical network switching systems. The company begins the marketing and manufacturing of its intelligent optical network system.

Tavolo offers an online store that enables its users to find and buy products related to cooking. Tavolo was acquired by OurHouse in December 2000. It is based in San Rafael, California.

CyOptics, Inc. is a company specializing in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, primarily for integration into access, metro, and long-haul communications systems. Its product offerings include planar lightwave circuits (PLCs) used in telecommunications and defense applications, as well as various optical components such as transmitters, receivers, and modulators. These products serve as critical technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with comprehensive design and manufacturing services, including radio frequency and optical design, wafer fabrication, and automated assembly and testing. The company caters to original equipment manufacturers and sub-system manufacturers within the communications market. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

BravoGifts.com is the first e-commerce site tailored exclusively to the needs of the business gift market. BravoGifts.com provides the highest levels of service to its customers through: selection - the widest selection of business gifts available anywhere; gift advice and services - advice and information on business gifts, gift searching, unique gift selection tools, and business gift etiquette; and convenience - everything is centralized in one easily accessible Internet location. The company boasts the broadest collection of brilliant business gifts from executive toys and gadgets, to golf and weekend getaways, theater and sports tickets, and gourmet foods.